Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY
Show Display Options
Rank Status Study
1 Completed Metabolic Consequences of CPT-1 Deficiency
Condition: Carnitine Palmitoyl Transferase Type 1A (CPT1A) Deficiency
Intervention: Other: Medically supervised fasting
2 Not yet recruiting Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD) Extension Study for Subjects Previously Enrolled in Triheptanoin Studies.
Conditions: Carnitine Palmitoyltransferase (CPT I or CPT II) Deficiency;   Very Long Chain Acyl-CoA Dehydrogenase (VLCAD) Deficiency;   Long-chain 3-hydroxy-acyl-CoA Dehydrogenase (LCHAD) Deficiency;   Trifunctional Protein (TFP) Deficiency;   Carnitine-acylcarnitine Translocase (CACT) Deficiency
Intervention: Drug: UX007

Indicates status has not been verified in more than two years